NEW YORK, Dec. 9, 2020 /PRNewswire/ -- The current pandemic has been devastating for the global economy and has caused severe backlogs in hospitals. Additionally, a spike in demand for Personal Protective Equipment (PPE) and new disinfecting technologies has also been seen. For example, when it comes for PPE, the global market was valued at USD 52.7 Billion in 2019 and is expected to reach USD 92.5 Billion by 2025 while growing at a CAGR of 8.7% during 2020-2025, according to VynZ Research. As for new technologies for disinfection, a recent example comes from LG Electronics, which announced on Wednesday the launch of a disinfection robot that will assist in containing the spread of the vi

NovaBay urges stockholders to vote FOR all proxy proposals at the Special Meeting of Stockholders NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) ("NovaBay" or the "Company") announces that the largest institutional advisory firm, Institutional Shareholder Services (ISS), has recommended that NovaBay stockholders vote in favor of all of the Company's proxy proposals, specifically to authorize and approve the sale of its eyecare business (the "Asset Sale Proposal") and approve the voluntary liquidation and dissolution of the Company (the "Dissolution Proposal"). Proposal One (the Asset Sale Proposal) and Proposal Two (the Dissolution Proposal) are further described in the Definitive Proxy Statem

Online Avenova® sales increase 14% for the quarter and 19% for the nine months Sales and marketing expenses declined 25% for the quarter and 18% for the nine months reflecting digital marketing optimization NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) reports financial results for the three and nine months ended September 30, 2024. "Avenova sales through the online channel for the quarter increased 14% over the prior year, while we reduced our marketing spend by 25% in the same period as we further optimized our highly efficient digital marketing programs," said Justin Hall, CEO of NovaBay. "We saw continued momentum in Avenova online sales into the current quarter. Sales through Amazon

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) ("NovaBay" or the "Company") today announces that the Company has accepted a revised transaction proposal from PRN Physician Recommended Nutriceuticals, LLC ("PRN") to increase the base purchase price for the Company's eyecare business from $9.5 million to $11.5 million. The Company has entered into an amendment (the "Amendment") to its previously announced Asset Purchase Agreement, dated September 19, 2024, with PRN (the "Original PRN APA" and, as amended, the "PRN APA"). The Company's transaction with PRN remains subject to certain closing conditions, including receiving stockholder approval. "We are pleased to accept PRN's revised offer for the

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) ("NovaBay" or the "Company") announces that the Company's board of directors has determined that an unsolicited and non-binding offer from Refresh Acquisitions BidCo LLC ("Refresh") for an affiliate of Refresh to acquire the Company's Avenova® brand and related assets is a "Superior Proposal" to the Company's asset purchase agreement with PRN Physician Recommended Nutriceuticals, LLC ("PRN"). Refresh's unsolicited offer provides for terms that are substantially similar to the contemplated transaction with PRN, except that the Company would receive a purchase price of up to $11.5 million (compared with $9.5 million in the transaction with PRN), subj

This Acquisition Enhances PRN Physician Recommended Nutriceuticals' ("PRN") Product Portfolio of Science-Based Eye Health Products BLUE BELL, Pa., Sept. 20, 2024 /PRNewswire/ -- Acumen Health Holdings, LLC, a professionally recommended, consumer-preferred dietary supplements company focused on eye health and companion animals, announced today that its subsidiary, PRN Physician Recommended Nutriceuticals, LLC, has entered into a definitive asset purchase agreement to acquire the assets of the Avenova® brand (the "Brand") and business from NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) ("NovaBay"). The Brand offers several products for ocular health including cleansing sprays, absorbent wipes, and

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) ("NovaBay" or the "Company") announces it has entered into a definitive asset purchase agreement (the "Agreement") with PRN Physician Recommended Nutriceuticals, LLC ("PRN") to sell the assets of its Avenova® brand and business for $9.5 million in cash. The transaction has been approved by the Company's board of directors and is anticipated to close in the fourth quarter of 2024, subject to the satisfaction of customary closing conditions, including approval from the stockholders of NovaBay. "This transaction allows our stockholders to more fully realize the value we have created over the past 10 years with the Avenova brand. We are particularly pl

Eyecare product revenue increased 8% driven by higher sales of Avenova®-branded products through online channels Sales and marketing expenses declined 13% reflecting efficient growth through digital marketing optimization Balance sheet strengthened with $3.9 million financing in July Conference call begins at 4:30 p.m. Eastern time today NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) reports financial results for the three and six months ended June 30, 2024 and provides a business update. "Revenue growth was driven by higher Avenova sales through online channels including an expanded subscription customer base," said Justin Hall, CEO of NovaBay. "The number of Subscribe & Save cust

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) announces that it will report financial results for the three and six months ended June 30, 2024 after market close on Tuesday, August 13, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time: Tuesday, August 13, 4:30 p.m. ET / 1:30 p.m. PT   Pre-Registration: Participants can pre-register for the conference call here:   Callers who pre-register will be emailed conference details and unique Registration ID to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) reports record sales of Avenova®-branded eyecare products during the Amazon Prime Day event, which was held July 16-17, 2024. Over the two-day period, Avenova sales were 17% higher compared with Prime Day 2023 and were up 40% over Prime Day 2022. "We reached another new sales record during the 2024 Amazon Prime Day event as consumers took advantage of discounts on our high-quality Avenova products," said Justin Hall, NovaBay CEO. "This event offered great pricing to our repeat customers on the Avenova products they've come to rely on, as well as to those new to our brand and our best-in-class dry eye product portfolio." "In recent years the preva

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) (the "Company" or "NovaBay") today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants, Series F-1 warrants, Series F-2 warrants and Series F-3 warrants for gross proceeds of approximately $3.87 million, prior to deducting underwriting discounts and commissions and offering expenses. The offering proceeds include partial exercise of the underwriter's over-allotment option to purchase additional shares of common stock, Series F-1 warrants, Series F-2 warrants and Series F-3 warrants. The offering consisted of a total of 1,158,566 shares of common stock, pre-funded warrants to purchase u

Net revenue from the Company's eyecare products increased by 9% for both the second quarter and the first half of 2024 over the corresponding periods in 2023. NovaBay also expects 2024 net revenue from the Company's eyecare products to be approximately $10 million. 

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY), a company developing and commercializing high-quality eyecare products, and Eyenovia, Inc. (NASDAQ:EYEN), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, have commenced activities under a previously announced co-promotion agreement. Under the agreement, Eyenovia is leveraging its ten-person field salesforce to promote NovaBay's Avenova Antimicrobial Lid & Lash Solution to large ophthalmic surgery centers along with one of Eyenovia's other FDA-approved products, MydCombi for mydriasis. In parallel, NovaBay has initiated reconnaissance and market preparation activities ahead

Gainers Avidity Biosciences (NASDAQ:RNA) shares rose 24.5% to $36.0 during Wednesday's pre-market session. The company's market cap stands at $3.4 billion. Molecular Partners (NASDAQ:MOLN) shares moved upwards by 18.43% to $5.91. The market value of their outstanding shares is at $196.1 million. Longeveron (NASDAQ:LGVN) shares increased by 15.84% to $0.95. The company's market cap stands at $6.0 million. TRACON Pharma (NASDAQ:TCON) shares increased by 15.74% to $1.25. The market value of their outstanding shares is at $3.3 million. Oramed Pharmaceuticals (NASDAQ:ORMP) stock moved upwards by 14.49% to $2.37. The market value of their outstanding shares is at $96.2 million. NovaBay Pharm

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 300 points on Thursday. The Dow traded down 0.83% to 38,122.78 while the NASDAQ fell 0.67% to 16,807.02. The S&P 500 also fell, dropping, 0.36% to 5,247.83. Check This Out: How To Earn $500 A Month From Nvidia Stock Following Strong Earnings Report Leading and Lagging SectorsReal estate shares rose by 1.3% on Thursday. In trading on Thursday, information technology shares dipped by 1.3%. Top Headline Best Buy Co., Inc (NYSE:BBY) reported better-than-expected earnings for its fiscal first quarter. The company posted adjusted EPS of $1.20, beating the street view of $1.08. Quart

Shares of American Eagle Outfitters, Inc. (NYSE:AEO) fell during Thursday's session following first-quarter results. American Eagle Outfitters reported adjusted earnings of 17 cents per share and quarterly revenue of $1.143 billion, up from $1.08 billion from the same period last year, but below the analyst estimate of $1.15 billion, according to data from Benzinga Pro. American Eagle Outfitters sees second-quarter operating income in a range of $95 million to $100 million and fiscal-year 2024 operating income in a range of $445 million and $465 million. American Eagle Outfitters shares fell 4.5% to $22.98 on Thursday. Here are some other stocks moving in today’s mid-day session.

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Thursday. The Dow traded down 1.01% to 38,055.10 while the NASDAQ fell 0.64% to 16,812.30. The S&P 500 also fell, dropping, 0.48% to 5,241.69. Check This Out: How To Earn $500 A Month From Nvidia Stock Following Strong Earnings Report Leading and Lagging SectorsReal estate shares rose by 1.3% on Thursday. In trading on Thursday, information technology shares dipped by 1.7%. Top Headline The EIA said stocks of crude oil in the U.S. fell by 4.16 million barrels in the week ending May 24 compared to market estimates of a 1.95 million barrels fall. Equities Trading UP  

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Thursday. Following the market opening Thursday, the Dow traded down 0.83% to 38,123.16 while the NASDAQ fell 0.20% to 16,887.52. The S&P 500 also fell, dropping, 0.22% to 5,255.22. Check This Out: How To Earn $500 A Month From Nvidia Stock Following Strong Earnings Report Leading and Lagging SectorsReal estate shares rose by 0.9% on Thursday. In trading on Thursday, information technology shares dipped by 1%. Top Headline Dollar General Corp (NYSE:DG) reported better-than-expected first-quarter financial results on Thursday. Dollar General reported first-quarter FY24 sales g

Shares of Pure Storage, Inc. (NYSE:PSTG) rose sharply in today's pre-market trading following better-than-expected first-quarter financial results. Pure Storage reported quarterly earnings of 32 cents per share, which beat the analyst consensus estimate of 21 cents. Quarterly sales clocked in at $693.479 million, beating the analyst consensus estimate of $680.972 million, according to data from Benzinga Pro. Pure Storage shares jumped 10.5% to $69.60 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers Smart for Life, Inc. (NASDAQ:SMFL) rose 60.5% to $6.27 in today's pre-market trading after gaining around 17% on Wednesday. Smart